Xanatos
Xanatos is a research and development company focused on "Forging the Future - Life Without Limits." Their primary areas of research include Life Extension Genetics, Artificial Intelligence (A.I.) Robotics, and Fusion Energy. In Life Extension Genetics, Xanatos explores telomere science, aiming to reverse or slow the aging process through genetic manipulation and the activation of telomerase. Their A.I. Robotics division focuses on developing cognitive architectures for Artificial General Intelligence (AGI), moving beyond current machine learning and neural network limitations to create more human-like consciousness and interaction in robots. The company's founder, David Julian Xanatos, is deeply involved in this research, developing sophisticated systems for sensory input (vision, hearing), motor functions, and language processing, aiming for true understanding rather than just pattern matching. While specific traction metrics are not provided, Xanatos is actively pursuing these advanced technologies, with a stated goal of integrating them to create a future with extended human lifespans and advanced artificial intelligence.
Xanatos
Xanatos is a research and development company focused on "Forging the Future - Life Without Limits." Their primary areas of research include Life Extension Genetics, Artificial Intelligence (A.I.) Robotics, and Fusion Energy. In Life Extension Genetics, Xanatos explores telomere science, aiming to reverse or slow the aging process through genetic manipulation and the activation of telomerase. Their A.I. Robotics division focuses on developing cognitive architectures for Artificial General Intelligence (AGI), moving beyond current machine learning and neural network limitations to create more human-like consciousness and interaction in robots. The company's founder, David Julian Xanatos, is deeply involved in this research, developing sophisticated systems for sensory input (vision, hearing), motor functions, and language processing, aiming for true understanding rather than just pattern matching. While specific traction metrics are not provided, Xanatos is actively pursuing these advanced technologies, with a stated goal of integrating them to create a future with extended human lifespans and advanced artificial intelligence.